The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hadfield Robert since 2020.
This trader's CIK number is 1630687.
At the time of last reporting, Hadfield Robert was the General Counsel and Secretary of Ziopharm Oncology Inc. (stock ticker symbol ZIOP).
Also see all insider trading activities at Ziopharm Oncology Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ZIOP | 0 | $0 | 26,500 | $82,680 | 0 | $0 |
| 2020 | ZIOP | 0 | $0 | 16,853 | $76,681 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-08 | ZIOP | Sale | 26,500 | 3.12 | 82,680 |
| 2020-01-02 | ZIOP | Sale | 16,853 | 4.55 | 76,681 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hadfield Robert (General Counsel and Secretary of Ziopharm Oncology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.